Takeda and Protagonist Therapeutics have submitted a new drug application to the FDA for rusfertide for adults with ...

A recent meta-analysis concerning short-form video, mental health, and attention spawned a lot of tech panic. Did critics ...

A study by Tinder-owner Match Group, “Singles in America”, shows that 26% of people are using AI tools in dating, while the ...

It's hardly a revelation that we're living in an era of distraction and smartphone addiction. Our phones interrupt us, hijack ...

Atacicept is a recombinant fusion protein that binds to and inhibits the activity of BAFF (B-cell activating factor) and APRIL (a proliferation-inducing ligand).

More people are resolving to spend less time on their phones and social media, and research suggests there are health ...

Admission to MIT demands far more than strong marks or test scores. The institute looks for students who can thrive in an ...

As consumer prices continue to fluctuate, thanks to things like inflation and tariffs, Walmart is opting to refresh its ...

Takeda & Protagonist submit NDA to US FDA seeking approval for rusfertide to treat polycythemia vera: Osaka, Japan Wednesday, January 7, 2026, 17:00 Hrs [IST] Takeda, focused on c ...

Writing things down isn't so common in the digital age we live in, but science shows there are major advantages to doing so.

The Faculty of Engineering at the University of Strathclyde, Glasgow, is offering a limited number of Dean’s International Excellence Awards for Master's Study worth between £9,000 and £12,000 to ...

The first major UK-based study into how AI companions are reshaping the emotional and social lives of young adults has raised concerns about risks.